|
The Safest Bet in Town! (OTCBB: SMME), (OTC Bulletin Board: LTUS), (OTCBB: ZORM)
(M2 PressWIRE Via Acquire Media NewsEdge) ****************************************************************************************
PENNY STOCK BETS: www.pennystockbets.com Your Safest Bet in Town!
Don't gamble with your financial future, Subscribe to our FREE newsletter and stay current with the latest stock picks.
*** SIGN UP AT www.pennystockbets.com
***
Earn money without losing anything,Contact us at info@pennystockbets.com
*****************************************************************************************
SmartMetric Announces Its Fingerprint Biometric Card Can Now Be Used to Hold Personal Medical Records Without Security Compromise
BAY HARBOR, FL, Aug 26, 2010
SmartMetric, Inc. (OTCBB: SMME) announced today that its fingerprint activated Biometric Data Card can be now used to provide the highest level of both security and portability for a person's medical history and full medical records.
Colin Hendrick, President and CEO, stated, "Once again our research and development team has pioneered another exciting breakthrough in our Biometric Data Card. We believe that nothing like this exists anywhere in the world today. We are currently in negotiations with several worldwide corporate entities regarding the rollout and commercialization of our breakthrough products. We will be updating our shareholders as soon as possible on the status of these talks, as well as our previously announced legal actions against Visa and MasterCard."
Unlike other portable solutions, the SmartMetric Data Card can store Gigabytes of medical information including full EKGs, complete CT and MRI digital images, and similar data making up an individual person's complete medical records. Storage of digital images, in particular, requires significant digital storage capacities. Unlike other systems that are severely limited in the amount of digital data that can be held in a portable solution, the SmartMetric Data Card is in fact a powerful digital computer with significant memory capacity sitting inside a Data Card the size of a standard Health Insurance Card. Most importantly, the SmartMetric solution provides the highest level of portable security for the patients information in that it can only be accessed after the patient touches the surface sensor on the Health Card triggering the Card to scan the persons fingerprint and matching it with their fingerprint pre-stored inside the card. Only after a finger print verification internally in the card is the data able to be accessed or viewed by a Doctor, Hospital or even an EMT's computer.
About SmartMetric, Inc.
SmartMetric, Inc. has developed a portable biometric identity and transaction card capable of storing a wide variety of personal information while protecting you against identity theft and fraud. It is one of the most advanced portable identity authentication solutions in the world today. The card contains a biometric fingerprint scanner and reader which only you can unlock and is smaller and thinner than a credit card. The SmartMetric card is ideal for a wide range of consumers, including Personal, Government and Corporate.
For more information please visit us at www.smartmetric.com
Safe Harbor Statement
Certain of the above statements contained in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those indicated in the forward-looking statements as a result of various factors.
-----------------------------------------------------------------------------------------
Lotus Pharmaceuticals Enter R-Bambuterol(R) Clinical Trial I
BEIJING, Aug 26, 2010
Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China (the "PRC"), announced today that it has entered R-Bambuterol(R) Clinical Trial I on-schedule and is on-track to complete in six months. The studies will evaluate the safety and tolerability of the new drug as well as the biological activity by measuring responses in healthy volunteers.
The studies are co-monitored by the Company and Beijing Zenith International Medical Science and Technology Development Company Limited, a mid-size full-service clinical research organization, and carried out in Peking University Third Hospital, a top-ranked AAA hospital recognized as a base adherence to the principles of good clinical practices (GCPs).
R-Bambuterol(R) Hydrochloride Tablets showed significant efficacy and less toxicity in preclinical trials as an anti-asthma drug than Bambuterol currently available in the market.
If it reaches the market, R-Bambuterol(R) Hydrochloride Tablets would address the Chinese asthma and chronic obstructive pulmonary disease (COPD) market led by AstraZeneca with a 26 percent share in 2009, according to IMS.
About Lotus Pharmaceuticals, Inc. ( http://www.lotuspharma.com )
Lotus Pharmaceuticals, Inc. is a growing developer and producer of drugs and a licensed national seller of pharmaceutical items in the PRC. Lotus operates its business through its two controlled entities: Liang Fang Pharmaceutical, Ltd. and En Ze Jia Shi Pharmaceutical, Ltd. Lotus' current drug development is focused on the treatment of cerebro-cardiovascular disease, asthma and diabetes. Liang Fang sells drugs directly and indirectly through its national sales channels to hospitals, clinics and drugs stores in 30 provinces of the PRC.
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intent," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may," or words or expressions of similar meaning. Such statements are not guarantees of future performance and could cause the actual results of the Company to differ materially from the results expressed or implied by such statements, including, but not limited to, changes from anticipated levels of sales, future national or regional economic and competitive and regulatory conditions, changes in relationships with customers, access to capital, increased costs, difficulties in developing and marketing new products, marketing existing products, customer acceptance of existing and new products, the time to get new drugs approved by the State Food and Drug Administration and other factors. Additional information regarding risks can be found in the Company's Annual Report on Form 10K and its other filings with the SEC. Accordingly, although the Company believes that the expectations reflected in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. The Company has no obligation to update the forward-looking information contained in this press release.
-----------------------------------------------------------------------------------
Zoro Mining Corp.-Corporate and Project Update
TUCSON, ARIZONA, Aug 26, 2010
Zoro Mining Corp. (OTCBB:ZORM) (the "Company") is pleased to provide the following update regarding recent corporate and project events which have transpired and which are planned.
As previously announced on July 21, 2010, the British Columbia Securities Commission (the "BCSC") revoked its cease trade order (the "CTO") issued on December 11, 2009 against the Company. As part of the information necessary to address the deficiencies cited by the BCSC under the CTO, the Company filed the following NI 43-101 Reports on SEDAR:
i. 43-101 Technical Report on the Yura Project, Arequipa, Peru; ii. 43-101 Technical Report on the Escondida Project, Region III, Copiapo, Chile; and iii. 43-101 Technical Report on the Don Beno Project, Region III, Copiapo, Chile.
These Technical Reports, which are available on SEDAR, discuss in considerable detail the merits of the properties that are covered. In particular, they have provided the Company with the basis upon which to design, and, pending sufficient funding, implement exploration programs. The priority of the Company at this time is to initiate exploration efforts at its Yura gold project near Arequipa, Peru. As set forth at page 1 of the Yura NI 43-101 Technical Report, "based on the results obtained to date the project warrants additional exploration. The program recommended for the 2010 season should include geologic mapping, rock chip and trench geochemistry surveys, remote sensing structural and alteration analysis followed by diamond drilling of the targets generated. The objective of the proposed program is to determine if the mineral targets defined by the 2010 program are sufficiently mineralized and large enough to warrant continued work to define a geologic resource."
The Company accordingly intends to initiate a capital raise in the amount of at least $385,000, which was identified as sufficient to fund the Phase 1 exploration budget at page 32 of the Technical Report.
The Company is also pleased to announce it has retained Bravo International Services ("Bravo") as its investor relations and corporate communications service provider. Bravo is a company owned by Larry K. Davis, an investor relations professional with over 20 years of experience providing investor relations services for junior public companies. Bravo will be responsible for building Zoro Mining's investment audience through the dissemination of corporate data packages, broker presentations, broker communications, mining analyst communications, attending trade shows and handling shareholder enquiries regarding the Company.
Zoro Mining Corp. is a mineral exploration company advancing a portfolio of six exploration stage gold projects in the mining-friendly countries of Chile and Peru, located in regions of historical and existing gold production. These projects, which in the aggregate, cover over 50,000 acres, represent a mix of potentially nearer-term, surface-mineable production, and longer-term, deeper exploration plays.
The Qualified Person responsible for the technical content of this news release is John Hiner, L.P. Geo., who has reviewed and approved the details contained herein.
Zoro Mining Corp. is also pleased to announce the launch of its new web site, www.zorominingcorp.com.
On Behalf of the Board
ZORO MINING CORP.
Andrew A. Brodkey, President and CEO
SAFE HARBOR STATEMENT
This document contains "forward-looking statements". Statements in this document, which are not purely historical, are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among others, the expectation and/or claim, as applicable, that (i) The Company intends to initiate a capital raise in the amount of at least $385,000, which was identified as sufficient to fund at least the Phase 1 exploration budget at page 32 of the Technical Report; and (ii) Zoro's projects represent a mix of potentially nearer-term, surface-mineable production, and longer-term, deeper exploration plays. It is important to note that actual outcomes and the Company's actual results could differ materially from those in such forward-looking statements. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others: (i) adverse market conditions; (ii) a decrease in demand for and price of gold, and base and precious metals; (iii) general uncertainties with respect to mineral exploration and development in general; (iv) changes in the political or regulatory environment in Chile, Peru and Mexico; (v) inability to raise required debt or equity financing or execute the Company's business plan; (vi) the failure by the Company to identify and acquire other mineral projects of merit;, (vii) the uncertainty of the requirements demanded by environmental agencies; (viii) the Company's ability to maintain qualified employees or consultants, and (ix) the likelihood that no commercial quantities of precious or base metals are found or recoverable on any properties in which the Company has or expects to gain an interest. The risks and uncertainties that could affect future events or the Company's future financial performance are more fully described in the Company's quarterly reports (on Form 10Q filed in the United States), the Company's annual reports (on Form 10K in the United States) and the other recent filings on Form 8K filed in the United States. These filings are available at www.sec.gov in the United States. There are numerous risks and uncertainties that could cause actual results and the Company's plans and objectives to differ materially from those expressed in the forward-looking information, including: (i) Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice.
*****************************************************************************************
About PennyStockBets.comPennyStockBets.com is written and published by PennyStockBets.com employees. Readers are advised that this analysis report is issued solely for informational purposes. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. PennyStockBets.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. For additional information, please visit www.PennyStockBets.com or e-mail info@PennyStockBets.com.
((Comments on this story may be sent to info@m2.com))
(c) 2010 M2 COMMUNICATIONS
[ Back To Homepage ]
|
